Delivery Order SPE2DR25D6035-SPE2DR26FBLGN
- Not listed
- The Defense Logistics Agency awarded a $2,102.33 delivery order to AmerisourceBergen Drug Corp on January 15, 2026, for the supply of Freestyle Libre 2 sensors, with an ultimate completion date of January 16, 2026. The contract is structured as a firm fixed-price delivery order with no set-aside designation, indicating competitive award. Performance will be executed at the awardee's corporate office located in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Freestyle Libre 2 Sensors under a firm fixed-price contract valued at $1,999.68. This non-set-aside delivery order, issued on July 25, 2025, with an ultimate completion date of July 28, 2025, represents a small-value procurement supporting federal medical supply needs. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company serves as a...
- The Defense Logistics Agency awarded a delivery order valued at $1,170.60 to AmerisourceBergen Drug Corp for the supply of FreeStyle Libre 2 sensors, with an ultimate completion date of January 7, 2026. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate office. AmerisourceBergen Drug Corp operates as a subsidiary of Cencora,...
- The Defense Logistics Agency awarded a delivery order valued at $5,261.89 to AmerisourceBergen Drug Corp for Freestyle Libre 2 Sensors on December 2, 2025, with completion scheduled for December 3, 2025. This competitively awarded, firm fixed-price delivery order represents a direct purchase of continuous glucose monitoring sensors to support federal healthcare needs. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,477.56 to AmerisourceBergen Drug Corp for Freestyle Libre 2 Sensors, with a completion deadline of September 3, 2025. This is a firm fixed price, competitively awarded delivery order with no set-aside designation. The work will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical vendor for federal medical procurement,...
- The Defense Logistics Agency awarded a delivery order valued at $1,278.12 to AmerisourceBergen Drug Corp for FreeStyle Libre 2 Sensors on July 29, 2025, with completion targeted for July 30, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The work will be performed at the contractor's corporate office...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 5, 2025, for the supply of Freestyle Libre 2 sensors, with a ceiling value of $2,119.11. This competitively awarded, firm fixed-price delivery order is part of AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The contract does not utilize a set-aside designation and is set for ultimate...
- The Defense Logistics Agency awarded a $1,271.80 firm fixed price delivery order to AmerisourceBergen Drug Corp on June 9, 2025, for the supply of FreeStyle Libre 2 sensors, with completion scheduled for June 10, 2025. This is a non-set-aside competitive award issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion global pharmaceutical support vehicle running through December 2026. The order will be fulfilled from...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,268.85 to AmerisourceBergen Drug Corp for Freestyle Libre 2 Sensors on August 25, 2025, with completion scheduled for August 26, 2025. This competitively awarded, firm fixed-price delivery order represents a small-value transaction under AmerisourceBergen's larger pharmaceutical supply relationship with DLA. The contract performs at the vendor's corporate office location in Conshohocken, Pennsylvania, with no set-aside...
- The Defense Logistics Agency awarded a delivery order valued at $6,706.33 to AmerisourceBergen Drug Corp on January 5, 2026, for the supply of FreeStyle Libre 2 sensors. This is a firm fixed price delivery order with an ultimate completion date of January 6, 2026, and represents a competitive award with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical and medical device distributor supporting federal medical...
- SPE2DR25D6035Indefinite Delivery Contract
- SPE2DR25D6035-SPE2DR26FBLGNDelivery Order
The Defense Logistics Agency awarded a $1,731.60 delivery order to AmerisourceBergen Drug Corp for Freestyle Libre 2 Sensors on January 21, 2026, with an ultimate completion date of January 22, 2026. This firm fixed-price contract utilizes no set-aside designation and represents a non-competitive delivery order under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. AmerisourceBergen Drug Corp is a subsidiary of parent company Cencora, Inc., a major pharmaceutical distributor serving federal government agencies. This delivery order falls under AmerisourceBergen's larger IDC with DLA Troop Support Medical valued at up to $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. The Freestyle Libre 2 Sensors are continuous glucose monitoring devices used for diabetes management within military treatment facilities and veterans' healthcare systems. AmerisourceBergen's established relationship with DLA as a prime pharmaceutical vendor demonstrates its capability to efficiently fulfill federal medical supply requirements across multiple therapeutic domains for the Department of Defense healthcare infrastructure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 1/20/26 |